Side-by-side comparison of AI visibility scores, market position, and capabilities
News Corp Class A shares (one vote each); same underlying $10.1B FY2024 revenue business as NWS; WSJ, Dow Jones, HarperCollins, REA Group; Murdoch family Class B supervoting control structure.
News Corp Class A (Nasdaq: NWSA) represents the voting shares of News Corp, a global media and information services company controlled by the Murdoch family through Class B supervoting shares, founded as the successor entity when the original News Corporation was separated in 2013 into Fox Corporation (broadcast and cable news entertainment) and News Corp (publishing, digital real estate, and information services). Headquartered in New York City, News Corp generated approximately $10.1 billion in revenues for fiscal year 2024 (ending June 2024) under CEO Robert Thomson. The Class A shares carry one vote per share, while Rupert Murdoch's family trust holds Class B shares with 10 votes per share that maintain controlling governance—a structure common in media companies founded by entrepreneur families who wish to retain editorial and strategic control through public capital markets financing.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.